20.42

2.00% 0.40

After Hours: 20.12 -0.30 -1.47%

Sabra Healthcare Reit Inc (SBRA)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Sabra Healthcare Reit Inc stock is traded at $20.42, with a volume of 2.00M. It is up +2.00% in the last 24 hours and up +7.30% over the past month. Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.

Previous Close:

$20.02

Open:

$19.94

24h Volume:

2.00M

Relative Volume:

0.73

Market Cap:

$5.15B

Revenue:

$773.78M

Net Income/Loss:

$155.51M

P/E Ratio:

31.91

EPS:

0.6399

Net Cash Flow:

$355.38M

1W Performance:

-0.63%

1M Performance:

+7.30%

6M Performance:

+7.30%

1Y Performance:

+23.23%

1-Day Range:

$19.91

$20.43

1-Week Range:

$19.91

$20.78

52-Week Range:

$15.75

$21.07

Sabra Healthcare Reit Inc Stock (SBRA) Company Profile

Name

Sabra Healthcare Reit Inc

Sector

Real Estate (261)

Industry

REIT - Healthcare Facilities (17)

Phone

888-393-8248

Address

1781 FLIGHT WAY, TUSTIN, CA

Employee

Twitter

Next Earnings Date

2024-10-31

Latest SEC Filings

SBRA's Discussions on Twitter

Compare SBRA vs WELL, VTR, OHI, DOC, AHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SBRA Sabra Healthcare Reit Inc	20.42	5.05B	773.78M	155.51M	355.38M	0.6399
WELL Welltower Inc	204.29	143.07B	10.83B	961.84M	2.11B	-0.7091
VTR Ventas Inc	84.87	40.35B	5.83B	261.52M	1.32B	0.5422
OHI Omega Healthcare Investors Inc	47.69	13.91B	1.08B	448.00M	779.91M	1.61
DOC Healthpeak Properties Inc	17.28	12.10B	2.80B	-10.95M	1.15B	-0.0564
AHR American Healthcare Reit Inc	51.51	9.29B	2.07B	-37.81M	84.15M	-0.27

Sabra Healthcare Reit Inc Stock (SBRA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-18-25	Initiated	UBS	Neutral
Oct-01-25	Initiated	Cantor Fitzgerald	Neutral
Jan-17-25	Downgrade	Truist	Buy → Hold
Jan-07-25	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Dec-05-24	Downgrade	Mizuho	Outperform → Neutral
Oct-01-24	Upgrade	Wells Fargo	Equal Weight → Overweight
Sep-13-24	Upgrade	Citigroup	Neutral → Buy
Jan-30-24	Initiated	Deutsche Bank	Buy
Oct-17-23	Downgrade	BMO Capital Markets	Outperform → Market Perform
Oct-16-23	Upgrade	Wells Fargo	Underweight → Equal Weight
Oct-10-23	Upgrade	BofA Securities	Neutral → Buy
Oct-03-23	Initiated	Wedbush	Outperform
Sep-20-23	Upgrade	Jefferies	Hold → Buy
Aug-11-23	Upgrade	BofA Securities	Underperform → Neutral
Jul-27-23	Initiated	Berenberg	Hold
Apr-20-23	Initiated	Wells Fargo	Underweight
Dec-13-22	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Nov-14-22	Downgrade	BofA Securities	Neutral → Underperform
Oct-10-22	Downgrade	Robert W. Baird	Outperform → Neutral
Jun-30-22	Downgrade	Jefferies	Buy → Hold
Jun-03-22	Initiated	CapitalOne	Equal Weight
May-25-22	Upgrade	Mizuho	Neutral → Buy
Apr-18-22	Downgrade	Barclays	Overweight → Equal Weight
Mar-11-22	Upgrade	BofA Securities	Underperform → Neutral
Feb-18-22	Initiated	KeyBanc Capital Markets	Sector Weight
Feb-01-22	Initiated	Credit Suisse	Neutral
Oct-08-21	Initiated	Robert W. Baird	Outperform
Sep-30-21	Upgrade	Truist	Hold → Buy
Jul-14-21	Resumed	Mizuho	Neutral
May-21-21	Upgrade	BMO Capital Markets	Market Perform → Outperform
May-10-21	Upgrade	Stifel	Hold → Buy
Jan-13-21	Upgrade	Jefferies	Hold → Buy
Jan-13-21	Downgrade	Mizuho	Buy → Neutral
Jan-08-21	Upgrade	BMO Capital Markets	Underperform → Market Perform
Dec-03-20	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Sep-02-20	Resumed	Stifel	Hold
Jun-23-20	Upgrade	Scotiabank	Sector Underperform → Sector Perform
Jun-08-20	Resumed	JMP Securities	Mkt Perform
May-18-20	Upgrade	Berenberg	Hold → Buy
Mar-23-20	Downgrade	BofA/Merrill	Neutral → Underperform
Feb-26-20	Upgrade	Mizuho	Neutral → Buy
Feb-05-20	Initiated	Berenberg	Hold
Dec-20-19	Initiated	Mizuho	Neutral
Dec-18-19	Upgrade	Citigroup	Sell → Neutral
Oct-14-19	Resumed	BofA/Merrill	Neutral
Sep-23-19	Downgrade	Citigroup	Neutral → Sell
Sep-03-19	Initiated	Barclays	Overweight
Dec-18-18	Downgrade	SunTrust	Buy → Hold
Nov-16-18	Downgrade	BofA/Merrill	Neutral → Underperform
May-21-18	Upgrade	Raymond James	Mkt Perform → Outperform
Mar-26-18	Upgrade	BofA/Merrill	Underperform → Neutral
Feb-22-18	Reiterated	Stifel	Hold
Dec-21-17	Downgrade	Jefferies	Buy → Hold
Sep-25-17	Initiated	CapitalOne	Equal Weight

View All

Sabra Healthcare Reit Inc Stock (SBRA) Latest News

Mar 05, 2026

Sabra Health Care REIT Hits New 52-Week High at $21.07 - Markets Mojo

Mar 05, 2026

Mar 03, 2026

Sabra Health Care (SBRA) director granted 781 dividend-equivalent units - Stock Titan

Mar 03, 2026

[Form 4] Sabra Health Care REIT, Inc. Insider Trading Activity - Stock Titan

Mar 03, 2026

Director Lynne Katzmann receives 781 SBRA stock units under 2009 plan - Stock Titan

Mar 03, 2026

Sabra Health Care REIT (SBRA) director credited 781 dividend-equivalent stock units - Stock Titan

Mar 03, 2026

Director at Sabra Health Care REIT (SBRA) receives 781 stock units award - Stock Titan

Mar 03, 2026

Dividend-based 781-unit stock grant to Sabra (SBRA) board director - Stock Titan

Mar 03, 2026

Sabra Health Care REIT (SBRA) EVP granted dividend-equivalent stock units - Stock Titan

Mar 03, 2026